Arrowstreet Capital’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-58,888	Closed	-$2.49M	–	1837
2024 Q1	$2.49M	Buy	58,888 +19,332	+49%	+$814K	﹤0.01%	1082
2023 Q4	$1.65M	Sell	39,556 -31,314	-44%	-$1.15M	﹤0.01%	999
2023 Q3	$2.67M	Buy	+70,870	New	+$2.66M	﹤0.01%	784
2021 Q3	–	Sell	-4,328	Closed	-$311K	–	1927
2021 Q2	$311K	Buy	+4,328	New	+$318K	﹤0.01%	1741
2020 Q4	–	Sell	-23,607	Closed	-$1.29M	–	2593
2020 Q3	$1.29M	Sell	23,607 -16,583	-41%	-$1.03M	﹤0.01%	1740
2020 Q2	$2.67M	Buy	40,190 +36,190	+905%	+$2.43M	﹤0.01%	1340
2020 Q1	$245K	Sell	4,000 -50,506	-93%	-$3.74M	﹤0.01%	1684
2019 Q4	$4.79M	Sell	54,506 -83,393	-60%	-$7.03M	0.01%	870
2019 Q3	$10.4M	Sell	137,899 -13,980	-9%	-$1.13M	0.02%	482
2019 Q2	$13M	Sell	151,879 -15,063	-9%	-$1.49M	0.03%	430
2019 Q1	$18M	Sell	166,942 -24,266	-13%	-$2.42M	0.04%	394
2018 Q4	$16.2M	Sell	191,208 -15,339	-7%	-$1.48M	0.04%	331
2018 Q3	$20.3M	Sell	206,547 -4,700	-2%	-$509K	0.05%	290
2018 Q2	$24.4M	Buy	211,247 +185,156	+710%	+$20.3M	0.06%	271
2018 Q1	$2.58M	Sell	26,091 -79,850	-75%	-$8.09M	0.01%	703
2017 Q4	$11.1M	Buy	+105,941	New	+$11.6M	0.03%	422
2016 Q2	–	Sell	-8,137	Closed	-$1.17M	–	1545
2016 Q1	$1.17M	Sell	8,137 -50,652	-86%	-$7.19M	﹤0.01%	933
2015 Q4	$9.08M	Buy	58,789 +47,338	+413%	+$6.91M	0.04%	376
2015 Q3	$1.63M	Buy	11,451 +221	+2%	+$30.9K	0.01%	798
2015 Q2	$1.61M	Buy	+11,230	New	+$1.6M	0.01%	690